ClinVar Miner

Submissions for variant NM_001330078.2(NRXN1):c.772+1078A>G

gnomAD frequency: 0.00153  dbSNP: rs144049982
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000153604 SCV000203147 likely benign not specified 2015-05-01 criteria provided, single submitter clinical testing
GeneDx RCV001704115 SCV000241846 likely benign not provided 2021-01-29 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000467253 SCV000431212 likely benign Pitt-Hopkins-like syndrome 2 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
Invitae RCV000467253 SCV000562380 likely benign Pitt-Hopkins-like syndrome 2 2024-02-01 criteria provided, single submitter clinical testing
Ambry Genetics RCV002316971 SCV000850190 uncertain significance Inborn genetic diseases 2018-08-14 criteria provided, single submitter clinical testing The p.D273G variant (also known as c.818A>G), located in coding exon 2 of the NRXN1 gene, results from an A to G substitution at nucleotide position 818. The aspartic acid at codon 273 is replaced by glycine, an amino acid with similar properties. Based on data from gnomAD, the G allele has an overall frequency of approximately 0.05% (141/264288) total alleles studied. The highest observed frequency was 0.56% (129/23136) of African alleles. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Baylor Genetics RCV000467253 SCV001519733 uncertain significance Pitt-Hopkins-like syndrome 2 2019-02-01 criteria provided, single submitter clinical testing This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868].

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.